{"ticker": "NABI", "overview": {"cik": "72444", "ticker": "VXRT", "name": "Vaxart, Inc.", "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "sic": "2836", "announcements": [{"form": "4", "date": "2026-10-20", "title": "FORM 4", "accession": "0001437749-26-033037", "price_sensitive": false}, {"form": "3", "date": "2026-10-20", "title": "FORM 3", "accession": "0001437749-26-033036", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-19", "title": "FORM 8-K", "accession": "0001437749-26-032932", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-14", "title": "FORM 8-K", "accession": "0001437749-26-030318", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-25", "title": "FORM 8-K", "accession": "0001437749-26-028916", "price_sensitive": true}, {"form": "10-Q", "date": "2026-08-06", "title": "FORM 10-Q", "accession": "0001437749-26-026289", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "FORM 8-K", "accession": "0001437749-26-026280", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-28", "title": "FORM 8-K", "accession": "0001437749-26-024560", "price_sensitive": true}, {"form": "4", "date": "2026-07-20", "title": "FORM 4", "accession": "0001437749-26-023863", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023810", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023809", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023808", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023807", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-17", "title": "FORM 8-K", "accession": "0001437749-26-023762", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-07", "title": "FORM 8-K", "accession": "0001437749-26-022876", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-06", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075169", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-07-02", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075088", "price_sensitive": false}, {"form": "DFAN14A", "date": "2026-07-02", "title": "Form DFAN14A", "accession": "0000921895-26-001714", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-02", "title": "CURRENT REPORT", "accession": "0001213900-26-074576", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-01", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-074234", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072735", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072727", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-26", "title": "FORM 8-K", "accession": "0001437749-26-021833", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072363", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072359", "price_sensitive": false}]}, "description": "NABI trades as NABI. Privy Trades holds 196 insider filings for the company, from October 2003 to April 2012. Across those, 15 insiders disclosed 10 open-market purchases totalling $6.44M against 64 sales totalling $7.56M. The most recent filing on record is dated 5 April 2012.", "exchange": null, "stats": {"buy_n": 10, "buy_sum": 6441109.96, "sell_n": 64, "sell_sum": 7560568.3239, "net": -1119458.3639000002, "insiders": 15, "first_date": "2003-10-28", "last_date": "2012-04-05"}, "metrics": {"ticker": "NABI", "has_prices": false}, "trades": [{"id": "0001491877-12-000022", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Paul D. Kessler", "who_key": "Kessler Paul D.", "role": "SVP Clinical, Med. & Reg.; CMO", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 9817.3, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider offloads $10K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187712000022/0001491877-12-000022-index.htm", "trade_date": "2012-04-05", "timestamp": "2012-04-05", "mins": 7667570}, {"id": "0001491877-11-000010", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on NABI \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187711000010/0001491877-11-000010-index.htm", "trade_date": "2011-05-25", "timestamp": "2011-05-25", "mins": 8122610}, {"id": "0001491877-11-000011", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Geoffrey F. Cox", "who_key": "COX GEOFFREY F", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on NABI \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187711000011/0001491877-11-000011-index.htm", "trade_date": "2011-05-25", "timestamp": "2011-05-25", "mins": 8122610}, {"id": "0001491877-11-000012", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Richard A. Harvey Jr", "who_key": "HARVEY RICHARD A JR", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on NABI \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187711000012/0001491877-11-000012-index.htm", "trade_date": "2011-05-25", "timestamp": "2011-05-25", "mins": 8122610}, {"id": "0001491877-11-000013", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Timothy P. Lynch", "who_key": "LYNCH TIMOTHY P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on NABI \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187711000013/0001491877-11-000013-index.htm", "trade_date": "2011-05-25", "timestamp": "2011-05-25", "mins": 8122610}, {"id": "0001491877-11-000014", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "David L. Castaldi", "who_key": "CASTALDI DAVID L", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on NABI \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187711000014/0001491877-11-000014-index.htm", "trade_date": "2011-05-25", "timestamp": "2011-05-25", "mins": 8122610}, {"id": "0001491877-11-000015", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Peter B. Davis", "who_key": "DAVIS PETER B", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on NABI \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187711000015/0001491877-11-000015-index.htm", "trade_date": "2011-05-25", "timestamp": "2011-05-25", "mins": 8122610}, {"id": "0001455244-11-000025", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Paul D. Kessler", "who_key": "Kessler Paul D.", "role": "SVP Clinical, Med. & Reg.; CMO", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 68158.6908, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider offloads $68K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000025/0001455244-11-000025-index.htm", "trade_date": "2011-05-16", "timestamp": "2011-05-16", "mins": 8135570}, {"id": "0001455244-11-000015", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Paul D. Kessler", "who_key": "Kessler Paul D.", "role": "SVP Clinical, Med. & Reg.; CMO", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 49479.4356, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider offloads $49K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000015/0001455244-11-000015-index.htm", "trade_date": "2011-04-05", "timestamp": "2011-04-05", "mins": 8194610}, {"id": "0001455244-11-000021", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Raafat E. F. Fahim", "who_key": "FAHIM RAAFAT E F", "role": "President, CEO and CFO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 76458.2763, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO sells $76K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000021/0001455244-11-000021-index.htm", "trade_date": "2011-04-05", "timestamp": "2011-04-05", "mins": 8194610}, {"id": "0001455244-11-000019", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Matthew W. Kalnik", "who_key": "Kalnik Matthew W.", "role": "SVP Strategic Plan. & Bus. Ops", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 36529.92, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider sells $37K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000019/0001455244-11-000019-index.htm", "trade_date": "2011-04-01", "timestamp": "2011-04-01", "mins": 8200370}, {"id": "0001455244-11-000008", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 19828.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Board member offloads $20K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000008/0001455244-11-000008-index.htm", "trade_date": "2011-03-14", "timestamp": "2011-03-14", "mins": 8226290}, {"id": "0001455244-11-000002", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Paul D. Kessler", "who_key": "Kessler Paul D.", "role": "SVP Clinical, Med. & Reg.; CMO", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 16869.1305, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider trims $17K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000002/0001455244-11-000002-index.htm", "trade_date": "2011-01-05", "timestamp": "2011-01-05", "mins": 8324210}, {"id": "0001455244-11-000004", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Raafat E. F. Fahim", "who_key": "FAHIM RAAFAT E F", "role": "President, CEO and CFO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 17972.65, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO offloads $18K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000004/0001455244-11-000004-index.htm", "trade_date": "2011-01-05", "timestamp": "2011-01-05", "mins": 8324210}, {"id": "0001455244-10-000151", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 86633.82, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Boardroom sells $87K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000151/0001455244-10-000151-index.htm", "trade_date": "2010-12-27", "timestamp": "2010-12-27", "mins": 8337170}, {"id": "0001455244-10-000147", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 10946.18, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "A director trims NABI: $11K", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000147/0001455244-10-000147-index.htm", "trade_date": "2010-12-15", "timestamp": "2010-12-15", "mins": 8354450}, {"id": "0001455244-10-000149", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 10946.18, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "A director trims NABI: $11K", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000149/0001455244-10-000149-index.htm", "trade_date": "2010-12-15", "timestamp": "2010-12-15", "mins": 8354450}, {"id": "0001455244-10-000145", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 25830.45, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Boardroom sells $26K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000145/0001455244-10-000145-index.htm", "trade_date": "2010-12-08", "timestamp": "2010-12-08", "mins": 8364530}, {"id": "0001455244-10-000143", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 37051.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director sells $37K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000143/0001455244-10-000143-index.htm", "trade_date": "2010-12-01", "timestamp": "2010-12-01", "mins": 8374610}, {"id": "0001455244-10-000141", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 42974.75, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "A director trims NABI: $43K", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000141/0001455244-10-000141-index.htm", "trade_date": "2010-11-22", "timestamp": "2010-11-22", "mins": 8387570}, {"id": "0001455244-10-000139", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 25970.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Boardroom sells $26K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000139/0001455244-10-000139-index.htm", "trade_date": "2010-11-11", "timestamp": "2010-11-11", "mins": 8403410}, {"id": "0001455244-10-000137", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 94078.4, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Boardroom sells $94K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000137/0001455244-10-000137-index.htm", "trade_date": "2010-11-10", "timestamp": "2010-11-10", "mins": 8404850}, {"id": "0001455244-10-000135", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 102950.53, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director sells $103K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000135/0001455244-10-000135-index.htm", "trade_date": "2010-10-20", "timestamp": "2010-10-20", "mins": 8435090}, {"id": "0001455244-10-000132", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 22110.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Boardroom sells $22K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000132/0001455244-10-000132-index.htm", "trade_date": "2010-10-11", "timestamp": "2010-10-11", "mins": 8448050}, {"id": "0001455244-10-000120", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Matthew W. Kalnik", "who_key": "Kalnik Matthew W.", "role": "SVP Strategic Plan. & Bus. Ops", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 8670.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider sells $9K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000120/0001455244-10-000120-index.htm", "trade_date": "2010-07-26", "timestamp": "2010-07-26", "mins": 8558930}, {"id": "0001455244-10-000118", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Matthew W. Kalnik", "who_key": "Kalnik Matthew W.", "role": "SVP Strategic Plan. & Bus. Ops", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 8905.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Someone inside NABI is selling \u2014 $9K worth", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000118/0001455244-10-000118-index.htm", "trade_date": "2010-07-19", "timestamp": "2010-07-19", "mins": 8569010}, {"id": "0001455244-10-000116", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 12323.78, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Board member offloads $12K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000116/0001455244-10-000116-index.htm", "trade_date": "2010-06-11", "timestamp": "2010-06-11", "mins": 8623730}, {"id": "0001455244-10-000128", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 3445.9799999999996, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Boardroom sells $3K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000128/0001455244-10-000128-index.htm", "trade_date": "2010-06-11", "timestamp": "2010-06-11", "mins": 8623730}, {"id": "0001435420-10-000002", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "SELL", "amount": 1498.9799999999998, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "A director trims NABI: $1K", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143542010000002/0001435420-10-000002-index.htm", "trade_date": "2010-06-03", "timestamp": "2010-06-03", "mins": 8635250}, {"id": "0001491877-10-000004", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "Geoffrey F. Cox", "who_key": "COX GEOFFREY F", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 9997.92, "score": 28.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Board member picks up $10K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187710000004/0001491877-10-000004-index.htm", "trade_date": "2010-05-20", "timestamp": "2010-05-20", "mins": 8655410}], "recent_buys": [{"id": "0001491877-10-000007", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "Peter B. Davis", "who_key": "DAVIS PETER B", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 19995.84, "score": 36.2, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "A director backs NABI with $20K", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187710000007/0001491877-10-000007-index.htm", "trade_date": "2010-05-20", "timestamp": "2010-05-20", "mins": 8655410}, {"id": "0001491877-10-000004", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "Geoffrey F. Cox", "who_key": "COX GEOFFREY F", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 9997.92, "score": 28.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Board member picks up $10K of NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187710000004/0001491877-10-000004-index.htm", "trade_date": "2010-05-20", "timestamp": "2010-05-20", "mins": 8655410}, {"id": "0001455244-09-000130", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "Peter B. Davis", "who_key": "DAVIS PETER B", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 14939.200000000003, "score": 33.3, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders pile into NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524409000130/0001455244-09-000130-index.htm", "trade_date": "2009-11-23", "timestamp": "2009-11-23", "mins": 8911730}, {"id": "0001104659-09-002351", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "David M. Knott", "who_key": "KNOTT DAVID M", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 224640.0, "score": 51.5, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders pile into NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000110465909002351/0001104659-09-002351-index.htm", "trade_date": "2009-01-12", "timestamp": "2009-01-12", "mins": 9365330}, {"id": "0000899140-07-000945", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "Third Point LLC", "who_key": "Third Point LLC", "role": "Insider", "person_type": "INSIDER", "person_label": "Insiders", "action": "BUY", "amount": 5922400.0, "score": 56.2, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders now buying NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000089914007000945/0000899140-07-000945-index.htm", "trade_date": "2007-05-10", "timestamp": "2007-05-10", "mins": 10248050}, {"id": "0000899140-06-001577", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "Third Point LLC", "who_key": "Third Point LLC", "role": "Insider", "person_type": "INSIDER", "person_label": "Insiders", "action": "BUY", "amount": 170887.5, "score": 36.9, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "NABI draws its 5th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000089914006001577/0000899140-06-001577-index.htm", "trade_date": "2006-11-03", "timestamp": "2006-11-03", "mins": 10518770}, {"id": "0001278819-05-000036", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "H. Le Roux Jooste", "who_key": "Jooste H Le Roux", "role": "Sr. VP, Glbl. Sales & Mktng.", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 35500.0, "score": 28.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "5 insiders now buying NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000127881905000036/0001278819-05-000036-index.htm", "trade_date": "2005-11-04", "timestamp": "2005-11-04", "mins": 11042930}, {"id": "0001278819-05-000035", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "Raafat E. F. Fahim", "who_key": "FAHIM RAAFAT E F", "role": "Sr. VP Tech. & Prod.", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 17300.0, "score": 36.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "6 insiders now buying NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000127881905000035/0001278819-05-000035-index.htm", "trade_date": "2005-11-03", "timestamp": "2005-11-03", "mins": 11044370}, {"id": "0001278819-05-000029", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "Raafat E. F. Fahim", "who_key": "FAHIM RAAFAT E F", "role": "Sr. VP Tech. & Prod.", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 24300.0, "score": 35.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 7 buying NABI", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000127881905000029/0001278819-05-000029-index.htm", "trade_date": "2005-06-08", "timestamp": "2005-06-08", "mins": 11257490}, {"id": "0001278819-04-000052", "src": "INSIDERS", "ticker": "NABI", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "NABI  BIOPHARMACEUTICALS", "who": "Thomas H. McLain", "who_key": "MCLAIN THOMAS H", "role": "Chairman, CEO and President, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 1149.5, "score": 41.7, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying NABI \u2014 7 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000127881904000052/0001278819-04-000052-index.htm", "trade_date": "2004-08-06", "timestamp": "2004-08-06", "mins": 11698130}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Third Point LLC", "who_key": "Third Point LLC", "role": "Insider", "person_type": "INSIDER", "person_label": "Insiders", "bought": 6093287.5, "sold": 0, "net": 6093287.5, "trades": 2, "top_score": 56.2, "lean": "buying", "history": [{"action": "BUY", "amount": 5922400.0, "date": "2007-05-10", "score": 56.2, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000089914007000945/0000899140-07-000945-index.htm"}, {"action": "BUY", "amount": 170887.5, "date": "2006-11-03", "score": 36.9, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000089914006001577/0000899140-06-001577-index.htm"}], "latest": {"action": "BUY", "amount": 5922400.0, "date": "2007-05-10", "score": 56.2, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000089914007000945/0000899140-07-000945-index.htm"}}, {"who": "Jason Aryeh", "who_key": "Aryeh Jason", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 4614003.8503, "net": -4614003.8503, "trades": 29, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 19828.0, "date": "2011-03-14", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000008/0001455244-11-000008-index.htm"}, {"action": "SELL", "amount": 86633.82, "date": "2010-12-27", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000151/0001455244-10-000151-index.htm"}, {"action": "SELL", "amount": 10946.18, "date": "2010-12-15", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000147/0001455244-10-000147-index.htm"}, {"action": "SELL", "amount": 10946.18, "date": "2010-12-15", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000149/0001455244-10-000149-index.htm"}, {"action": "SELL", "amount": 25830.45, "date": "2010-12-08", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000145/0001455244-10-000145-index.htm"}, {"action": "SELL", "amount": 37051.0, "date": "2010-12-01", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000143/0001455244-10-000143-index.htm"}, {"action": "SELL", "amount": 42974.75, "date": "2010-11-22", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000141/0001455244-10-000141-index.htm"}, {"action": "SELL", "amount": 25970.0, "date": "2010-11-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000139/0001455244-10-000139-index.htm"}, {"action": "SELL", "amount": 94078.4, "date": "2010-11-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000137/0001455244-10-000137-index.htm"}, {"action": "SELL", "amount": 102950.53, "date": "2010-10-20", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000135/0001455244-10-000135-index.htm"}, {"action": "SELL", "amount": 22110.0, "date": "2010-10-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000132/0001455244-10-000132-index.htm"}, {"action": "SELL", "amount": 12323.78, "date": "2010-06-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000116/0001455244-10-000116-index.htm"}, {"action": "SELL", "amount": 3445.9799999999996, "date": "2010-06-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000128/0001455244-10-000128-index.htm"}, {"action": "SELL", "amount": 1498.9799999999998, "date": "2010-06-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143542010000002/0001435420-10-000002-index.htm"}, {"action": "SELL", "amount": 406293.30329999997, "date": "2010-03-24", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000085/0001455244-10-000085-index.htm"}, {"action": "SELL", "amount": 177902.4, "date": "2010-03-22", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000083/0001455244-10-000083-index.htm"}, {"action": "SELL", "amount": 46722.0, "date": "2010-03-19", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000081/0001455244-10-000081-index.htm"}, {"action": "SELL", "amount": 39224.76, "date": "2010-03-18", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000077/0001455244-10-000077-index.htm"}, {"action": "SELL", "amount": 67881.24, "date": "2010-03-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000075/0001455244-10-000075-index.htm"}, {"action": "SELL", "amount": 1186.0, "date": "2010-03-15", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000066/0001455244-10-000066-index.htm"}, {"action": "SELL", "amount": 98374.0, "date": "2010-03-12", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000063/0001455244-10-000063-index.htm"}, {"action": "SELL", "amount": 92414.0, "date": "2010-03-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000040/0001455244-10-000040-index.htm"}, {"action": "SELL", "amount": 18392.96, "date": "2010-03-08", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000036/0001455244-10-000036-index.htm"}, {"action": "SELL", "amount": 75774.42, "date": "2010-01-13", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000032/0001455244-10-000032-index.htm"}, {"action": "SELL", "amount": 473367.30000000005, "date": "2010-01-12", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000030/0001455244-10-000030-index.htm"}], "latest": {"action": "SELL", "amount": 19828.0, "date": "2011-03-14", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000008/0001455244-11-000008-index.htm"}}, {"who": "David M. Knott", "who_key": "KNOTT DAVID M", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 224640.0, "sold": 496692.00000000006, "net": -272052.00000000006, "trades": 2, "top_score": 51.5, "lean": "selling", "history": [{"action": "SELL", "amount": 496692.00000000006, "date": "2009-06-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000110465909041476/0001104659-09-041476-index.htm"}, {"action": "BUY", "amount": 224640.0, "date": "2009-01-12", "score": 51.5, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000110465909002351/0001104659-09-002351-index.htm"}], "latest": {"action": "SELL", "amount": 496692.00000000006, "date": "2009-06-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000110465909041476/0001104659-09-041476-index.htm"}}, {"who": "David J. Gury", "who_key": "GURY DAVID J", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 709414.36, "net": -709414.36, "trades": 7, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 244186.96, "date": "2003-11-14", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120646603000011/0001206466-03-000011-index.htm"}, {"action": "SELL", "amount": 96931.4, "date": "2003-11-07", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120646603000010/0001206466-03-000010-index.htm"}, {"action": "SELL", "amount": 96764.0, "date": "2003-10-31", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120646603000008/0001206466-03-000008-index.htm"}, {"action": "SELL", "amount": 6660.0, "date": "2003-10-31", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000127881904000007/0001278819-04-000007-index.htm"}, {"action": "SELL", "amount": 79872.0, "date": "2003-10-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120646603000007/0001206466-03-000007-index.htm"}, {"action": "SELL", "amount": 66000.0, "date": "2003-10-29", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120646603000006/0001206466-03-000006-index.htm"}, {"action": "SELL", "amount": 119000.0, "date": "2003-10-28", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120646603000005/0001206466-03-000005-index.htm"}], "latest": {"action": "SELL", "amount": 244186.96, "date": "2003-11-14", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120646603000011/0001206466-03-000011-index.htm"}}, {"who": "Robert B. Naso", "who_key": "NASO ROBERT B", "role": "Sr. VP Qual., Reg., Prod. Dev.", "person_type": "EXEC", "person_label": "Execs", "bought": 0, "sold": 658435.3792, "net": -658435.3792, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 658435.3792, "date": "2003-10-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000111172803000003/0001111728-03-000003-index.htm"}], "latest": {"action": "SELL", "amount": 658435.3792, "date": "2003-10-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000111172803000003/0001111728-03-000003-index.htm"}}, {"who": "Paul D. Kessler", "who_key": "Kessler Paul D.", "role": "SVP Clinical, Med. & Reg.; CMO", "person_type": "EXEC", "person_label": "Execs", "bought": 0, "sold": 361573.3899, "net": -361573.3899, "trades": 9, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 9817.3, "date": "2012-04-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187712000022/0001491877-12-000022-index.htm"}, {"action": "SELL", "amount": 68158.6908, "date": "2011-05-16", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000025/0001455244-11-000025-index.htm"}, {"action": "SELL", "amount": 49479.4356, "date": "2011-04-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000015/0001455244-11-000015-index.htm"}, {"action": "SELL", "amount": 16869.1305, "date": "2011-01-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000002/0001455244-11-000002-index.htm"}, {"action": "SELL", "amount": 85685.29000000001, "date": "2010-05-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187710000002/0001491877-10-000002-index.htm"}, {"action": "SELL", "amount": 28031.08, "date": "2010-04-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000093/0001455244-10-000093-index.htm"}, {"action": "SELL", "amount": 3010.9030000000002, "date": "2009-11-23", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524409000133/0001455244-09-000133-index.htm"}, {"action": "SELL", "amount": 88861.18, "date": "2009-11-20", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524409000128/0001455244-09-000128-index.htm"}, {"action": "SELL", "amount": 11660.38, "date": "2008-03-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000139609308000010/0001396093-08-000010-index.htm"}], "latest": {"action": "SELL", "amount": 9817.3, "date": "2012-04-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000149187712000022/0001491877-12-000022-index.htm"}}, {"who": "Jordan I. Siegel", "who_key": "Siegel Jordan I", "role": "Sr. VP Fin. & Admin, CFO Treas", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 248833.46, "net": -248833.46, "trades": 2, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 220337.16999999998, "date": "2008-03-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000139609308000011/0001396093-08-000011-index.htm"}, {"action": "SELL", "amount": 28496.29, "date": "2008-03-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000139609308000008/0001396093-08-000008-index.htm"}], "latest": {"action": "SELL", "amount": 220337.16999999998, "date": "2008-03-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000139609308000011/0001396093-08-000011-index.htm"}}, {"who": "Matthew W. Kalnik", "who_key": "Kalnik Matthew W.", "role": "SVP Strategic Plan. & Bus. Ops", "person_type": "EXEC", "person_label": "Execs", "bought": 0, "sold": 223937.3382, "net": -223937.3382, "trades": 9, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 36529.92, "date": "2011-04-01", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000019/0001455244-11-000019-index.htm"}, {"action": "SELL", "amount": 8670.0, "date": "2010-07-26", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000120/0001455244-10-000120-index.htm"}, {"action": "SELL", "amount": 8905.0, "date": "2010-07-19", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000118/0001455244-10-000118-index.htm"}, {"action": "SELL", "amount": 13005.0, "date": "2010-04-13", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000095/0001455244-10-000095-index.htm"}, {"action": "SELL", "amount": 10693.5, "date": "2010-04-01", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000091/0001455244-10-000091-index.htm"}, {"action": "SELL", "amount": 58546.89, "date": "2010-03-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000071/0001455244-10-000071-index.htm"}, {"action": "SELL", "amount": 6693.75, "date": "2010-03-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000069/0001455244-10-000069-index.htm"}, {"action": "SELL", "amount": 12262.5, "date": "2010-03-02", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524410000034/0001455244-10-000034-index.htm"}, {"action": "SELL", "amount": 68630.7782, "date": "2009-11-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524409000119/0001455244-09-000119-index.htm"}], "latest": {"action": "SELL", "amount": 36529.92, "date": "2011-04-01", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000145524411000019/0001455244-11-000019-index.htm"}}], "activity": [], "announcements": [{"form": "4", "date": "2026-10-20", "title": "FORM 4", "accession": "0001437749-26-033037", "price_sensitive": false}, {"form": "3", "date": "2026-10-20", "title": "FORM 3", "accession": "0001437749-26-033036", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-19", "title": "FORM 8-K", "accession": "0001437749-26-032932", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-14", "title": "FORM 8-K", "accession": "0001437749-26-030318", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-25", "title": "FORM 8-K", "accession": "0001437749-26-028916", "price_sensitive": true}, {"form": "10-Q", "date": "2026-08-06", "title": "FORM 10-Q", "accession": "0001437749-26-026289", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "FORM 8-K", "accession": "0001437749-26-026280", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-28", "title": "FORM 8-K", "accession": "0001437749-26-024560", "price_sensitive": true}, {"form": "4", "date": "2026-07-20", "title": "FORM 4", "accession": "0001437749-26-023863", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023810", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023809", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023808", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023807", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-17", "title": "FORM 8-K", "accession": "0001437749-26-023762", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-07", "title": "FORM 8-K", "accession": "0001437749-26-022876", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-06", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075169", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-07-02", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075088", "price_sensitive": false}, {"form": "DFAN14A", "date": "2026-07-02", "title": "Form DFAN14A", "accession": "0000921895-26-001714", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-02", "title": "CURRENT REPORT", "accession": "0001213900-26-074576", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-01", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-074234", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072735", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072727", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-26", "title": "FORM 8-K", "accession": "0001437749-26-021833", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072363", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072359", "price_sensitive": false}], "performance": {"ticker": "NABI", "has_prices": false, "summary": null, "buys": [{"who": "DAVIS PETER B", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 19995.84, "date": "2010-05-20", "score": 36.2, "ref_price": null, "return": null}, {"who": "COX GEOFFREY F", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 9997.92, "date": "2010-05-20", "score": 28.7, "ref_price": null, "return": null}, {"who": "DAVIS PETER B", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 14939.200000000003, "date": "2009-11-23", "score": 33.3, "ref_price": null, "return": null}, {"who": "KNOTT DAVID M", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 224640.0, "date": "2009-01-12", "score": 51.5, "ref_price": null, "return": null}, {"who": "Third Point LLC", "person_type": "INSIDER", "person_label": "Insiders", "role": "Insider", "amount": 5922400.0, "date": "2007-05-10", "score": 56.2, "ref_price": null, "return": null}, {"who": "Third Point LLC", "person_type": "INSIDER", "person_label": "Insiders", "role": "Insider", "amount": 170887.5, "date": "2006-11-03", "score": 36.9, "ref_price": null, "return": null}, {"who": "Jooste H Le Roux", "person_type": "EXEC", "person_label": "Execs", "role": "Sr. VP, Glbl. Sales & Mktng.", "amount": 35500.0, "date": "2005-11-04", "score": 28.7, "ref_price": null, "return": null}, {"who": "FAHIM RAAFAT E F", "person_type": "EXEC", "person_label": "Execs", "role": "Sr. VP Tech. & Prod.", "amount": 17300.0, "date": "2005-11-03", "score": 36.1, "ref_price": null, "return": null}, {"who": "FAHIM RAAFAT E F", "person_type": "EXEC", "person_label": "Execs", "role": "Sr. VP Tech. & Prod.", "amount": 24300.0, "date": "2005-06-08", "score": 35.1, "ref_price": null, "return": null}, {"who": "MCLAIN THOMAS H", "person_type": "CEO", "person_label": "CEOs", "role": "Chairman, CEO and President, Director", "amount": 1149.5, "date": "2004-08-06", "score": 41.7, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}